Relapsed or Refractory Chronic Myelomonocytic Leukemia
specific3
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Relapsed or Refractory Chronic Myelomonocytic Leukemia(3)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Clinical | 66.7 |
| 2 | Cleveland Clinic Cancer CenterCleveland, OH | 66.7 |
| 3 | Boston University Cancer CenterBoston, MA | 66.7 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →